Indicators for Monitoring National Drug Policies
(1999; 250 pages) [French] View the PDF document
Table of Contents
View the documentACKNOWLEDGEMENTS
Open this folder and view contentsCHAPTER I: Introduction
Open this folder and view contentsCHAPTER II: Development of the manual
Open this folder and view contentsCHAPTER III: Model lists of indicators
Open this folder and view contentsCHAPTER IV: Methodology for indicator calculation
Open this folder and view contentsCHAPTER V: Detailed presentation of indicators
Close this folderANNEX 1: Data collection forms
View the documentData Collection Form 1 - Private drug outlets
View the documentData Collection Form 2 - Public sector drug outlets
View the documentData Collection Form 3 - Health facilities/prescribers
View the documentData Collection Form 4 - Remote health facilities
View the documentSummary Form 1 - National drug policy background information
View the documentSummary Form 2 - National drug policy structural indicators
View the documentSummary Form 3 - National drug policy process indicators
View the documentSummary Form 4 - National drug policy outcome indicators
View the documentANNEX 2: Glossary
View the documentANNEX 3: Table of random numbers
View the documentBACK COVER
 

Summary Form 2 - National drug policy structural indicators

Legislation and regulation


YES


NO





ST1: Is there an official national drug policy document updated in the past 10 years?


ST2: Is there drug legislation updated in the past 10 years?


ST3: Have regulations based on the drug legislation been issued?


ST4: Is there a drug regulatory authority whose mandate includes registration and inspection?


ST5: Is there a licensing system to regulate the sale of drugs (wholesalers, pharmacists, retailers)?


ST6: Are pharmacists legally entitled to substitute generic drugs for brand name products?


ST7: Are there legal provisions for penal sanctions?


ST8: Is there a checklist for carrying out inspections in different types of pharmaceutical establishments?


ST9: Are there any institutions within or outside the country where quality control is carried out?


ST10: Is the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce used systematically?


ST11: Are there controls on drug promotion based on regulations and consistent with the WHO Ethical Criteria for Medicinal Drug Promotion?


Essential drug selection and drug registration


YES


NO





ST12: Is there a national essential drugs list (EDL)/formulary using INN officially adopted and distributed countrywide?


ST13: Is there an official drug committee whose duties include updating the national essential drugs list (EDL)?


ST14: Has the national essential drugs list (EDL)/formulary been updated and distributed countrywide in the past five years?


ST15: Do drug donations comply with the national essential drugs list (EDL)?


ST16: Are there formal procedures for registering drugs?


ST17: Is there a drug registration committee?


ST18: Is drug registration renewal required at least every five years?


Drug allocation in the health budget/public sector financing policy


YES


NO





ST19: Is the public drug budget spent per year more than 20% of the ministry of health operating budget spent per year for the last three years?


ST20: Is the public drug budget spent per capita per year more than US$1.00 per year for the last three years?


ST21: Is the public drug budget spent for national hospitals less than 40% of the total public drug budget spent for the last three years?


ST22: Has the public drug budget spent per capita increased in the last three years?


ST23: Are there any financing systems in addition to the public drug budget that contribute to the provision of drugs in the public sector?


Public sector procurement procedures


YES


NO





ST24: Are drugs usually procured in the public sector through competitive tender?


ST25: Is there a system for monitoring supplier performance?


ST26: Is most of the tendering done under international nonproprietary name (INN)?


ST27: Does the procurement unit receive foreign currency in less than 60 days (from request to release)?


ST28: Is procurement in the public sector limited to drugs on the national essential drugs list (EDL)?


ST29: Is the average lead time (from order to receipt at central level) less than eight months?


ST30: Is procurement based on a reliable quantification of drug needs?


Public sector distribution and logistics


YES


NO





ST31: Are good storage practices observed in the central procurement/distribution unit and/or major regional warehouses?


ST32: Is the information recorded on the stockcards for a basket of drugs the same as the quantity of stock in store?


ST33: Are the stocks for a basket of drugs within their expiry dates in the central procurement/distribution unit and/or major regional warehouses?


ST34: Have all incoming products been physically inspected for the last three deliveries in the central procurement/distribution unit and/or in major regional warehouses?


ST35: Are only drugs which are on the national essential drugs list (EDL) in stock in the central procurement/distribution unit and/or in major regional warehouses?


ST36: Are 80% or more of the vehicles of the central procurement/distribution unit and/or major regional warehouses in working condition?


Pricing policy


YES


NO





ST37: Are drug prices regulated in the private sector?


ST38: Is there at least one major incentive for the private sector to sell essential drugs at low cost?


ST39: Is the total margin used by wholesalers and retailers less than 35% of the CIF price?


ST40: Is there a system for monitoring drug prices?


ST41: Are essential drugs under INN or generic name sold in private drug outlets?


Information and continuing education on drug use


YES


NO





ST42: Is there a national publication (formulary/bulletin/manual, etc.), revised within the past five years, providing objective information on drug use?


ST43: Is there a national therapeutic guide with standardized treatments?


ST44: Is the concept of essential drugs part of the curricula in the basic training of health personnel?


ST45: Is there an official continuing education system for rational use of drugs for prescribers and dispensers?


ST46: Is there a drug information unit/centre?


ST47: Does the drug information unit/centre (or another independent body) provide regular information on drugs to prescribers and dispensers?


ST48: Are there therapeutic committees in the major hospitals?


ST49: Are there public education campaigns on drug use?


ST50: Is drug education included in the primary/secondary school curricula?


to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014